The Metabolome as a Biomarker of Health and Aging in Companion Dogs
Daniel Promislow

TL;DR
The study explores how the metabolome can reveal health and aging patterns in dogs, offering insights into aging processes shared with humans.
Contribution
The study introduces a large-scale longitudinal analysis of the dog metabolome to identify biomarkers of aging and mortality.
Findings
Age-related changes in the metabolome correlate with breed-specific lifespan differences in dogs.
Certain metabolites predict mortality risk in dogs with patterns similar to those in humans.
Metabolome profiles connect genetic and environmental factors to aging-related traits.
Abstract
The companion dog is an exceptional translational model for understanding the causes and consequences of aging. Among breeds, we observe high levels of variation not only in morphology and behavior, but also in lifespan and the risk of specific diseases, many of which are common in humans. Dogs share our environment and, like us, have a sophisticated healthcare system. Their shorter lifespan relative to humans means that lessons that might take decades to learn from human longitudinal studies can be gleaned in just a few years by observing aging in dogs. Here, we share recent findings from the Dog Aging Project, a long-term longitudinal study designed to identify the genetic and environmental factors that influence healthy aging in dogs and the mechanisms by which they do so. As part of the Dog Aging Project, we collect annual measures of the plasma metabolome for nearly 1,000 dogs from…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHuman-Animal Interaction Studies · Veterinary Medicine and Surgery · Veterinary Oncology Research
